Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences

LEIDEN, Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that the company will present abstracts with pre-clinical data for its cystic fibrosis...
September 23, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable

LEIDEN, the Netherlands, Sept. 23, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
September 14, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment

LEIDEN, the Netherlands, Sept. 14, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that PQ-010-002 is open for enrollment. The primary objective of PQ-010-002 is to...
August 19, 2015 07:59 ET | Source: ProQR Therapeutics N.V.

ProQR Announces Results for the Second Quarter of 2015

LEIDEN, the Netherlands, Aug. 19, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
June 26, 2015 07:54 ET | Source: ProQR Therapeutics N.V.

ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients

LEIDEN, the Netherlands, June 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that enrollment has started in study PQ-010-001, a global Phase 1b clinical study of...
June 16, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR to Present at the JMP Securities Life Science Conference

LEIDEN, the Netherlands, June 16, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
May 21, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Therapeutics Announces Results for the First Quarter of 2015

LEIDEN, the Netherlands, May 21, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
April 29, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR to Present at Two Upcoming Investor Conferences in May

LEIDEN, the Netherlands, April 29, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), today announced that Daniel de Boer, Chief Executive Officer, will take part in a fireside chat at...
April 29, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Therapeutics Announces Annual Shareholder Meeting

LEIDEN, the Netherlands, April 29, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), today announced that the Annual General Meeting of Shareholders will be held on Wednesday, June 10,...
February 26, 2015 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014

LEIDEN, Netherlands, Feb. 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...